Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in gene therapy using adeno-associated virus vectors (AAV), specifically "production of neutralizing antibodies" and "hepatotoxicity," by employing a novel smart nanomachine equipped with AAV.
